Literature DB >> 16202013

Complications of therapeutic plasma exchange: experience with 4857 treatments.

Nikolina Basic-Jukic1, Petar Kes, Snjezana Glavas-Boras, Bruna Brunetta, Ljubica Bubic-Filipi, Zvonimir Puretic.   

Abstract

Plasma exchange (PE) is a technique of extracorporeal blood purification which removes large molecular weight substances from plasma. The Department of Dialysis, Zagreb University Hospital Center's database, which includes data on 509 patients, or 4857 PE treatments, was retrospectively analyzed to test the safety of PE. A total of 231 adverse reactions were recorded (4.75% of treatments). The most common complications were paresthesias (2.7%), hematoma at the puncture site (2.4%), clotting (1.7%), mild to moderate allergic reactions (urticaria; 1.6%) and bleeding (0.06%). True anaphylactoid reactions were recorded in five procedures. The incidence of severe, potentially life-threatening adverse reactions was 0.12%. The prophylactic use of calcium and potassium was responsible for a low incidence of electrolyte disturbances. There was no lethal outcome associated with PE. When carried out by experienced staff, PE is a relatively safe procedure. The use of fresh frozen plasma is associated with a higher rate of adverse reactions.

Entities:  

Mesh:

Year:  2005        PMID: 16202013     DOI: 10.1111/j.1744-9987.2005.00319.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  24 in total

Review 1.  Anticoagulation techniques in apheresis: from heparin to citrate and beyond.

Authors:  Grace Lee; Gowthami M Arepally
Journal:  J Clin Apher       Date:  2012-04-24       Impact factor: 2.821

2.  Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.

Authors:  Anil Tombak; Mehmet Ali Uçar; Aydan Akdeniz; Arda Yilmaz; Hakan Kaleagası; Mehmet Ali Sungur; Eyup Naci Tiftik
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-22       Impact factor: 0.900

3.  Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions.

Authors:  Tara Klemencic Kozul; Anna Yudina; Carley Donovan; Ashwin Pinto; Chinar Osman
Journal:  BMC Health Serv Res       Date:  2022-07-12       Impact factor: 2.908

4.  Minimising changes in plasma calcium and magnesium concentrations during plasmapheresis.

Authors:  Rajesh G Krishnan; Malcolm G Coulthard
Journal:  Pediatr Nephrol       Date:  2007-07-24       Impact factor: 3.714

5.  Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome.

Authors:  Jeffrey L Winters; David Brown; Elisabeth Hazard; Ashok Chainani; Chester Andrzejewski
Journal:  BMC Health Serv Res       Date:  2011-05-16       Impact factor: 2.655

6.  Plasmapheresis in a patient with "refractory" urticarial vasculitis.

Authors:  Ozgur Kartal; Mustafa Gulec; Zafer Caliskaner; Oral Nevruz; Turker Cetin; Osman Sener
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-14       Impact factor: 5.764

7.  Treatment of MuSK-Associated Myasthenia Gravis.

Authors:  Khalid El-Salem; Ahmed Yassin; Kefah Al-Hayk; Salma Yahya; Duha Al-Shorafat; Said S Dahbour
Journal:  Curr Treat Options Neurol       Date:  2014-04       Impact factor: 3.972

Review 8.  The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis.

Authors:  Emily Rimmer; Brett L Houston; Anand Kumar; Ahmed M Abou-Setta; Carol Friesen; John C Marshall; Gail Rock; Alexis F Turgeon; Deborah J Cook; Donald S Houston; Ryan Zarychanski
Journal:  Crit Care       Date:  2014-12-20       Impact factor: 9.097

Review 9.  Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.

Authors:  Karim Doughem; Ayman Battisha; Omar Sheikh; Lakshmi Konduru; Bader Madoukh; Mohammed Al-Sadawi; Shakil Shaikh
Journal:  Curr Cardiol Rev       Date:  2021

10.  Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.

Authors:  Yi-yan Zhang; Zheng Tang; Dong-mei Chen; De-hua Gong; Da-xi Ji; Zhi-hong Liu
Journal:  BMC Nephrol       Date:  2014-08-03       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.